A prospective clinical study conducted by the Karolinska Institute in Sweden has validated the performance of VolparaDensity breast imaging software across multiple vendor platforms and has associated volumetrically assessed breast density measurements to breast cancer risk.

Guided Therapeutics Inc. has filed an amendment to its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the LuViva Advanced Cervical Scan.

July 30, 2014 — A study by Gareen et al, published July 25 in Cancer, the incidence and effects of anxiety associated with false positive or other results of computed tomography (CT) lung cancer screening exams are far less than claimed by some in the medical community.

July 30, 2014 — ViewRay featured its MRIdian system at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM), held in Austin, Texas.

New study data presented at the Alzheimer’s Association Intl. Conference 2014 (AAIC) showed that a positive [18F]flutemetamol positron emission tomography (PET) scan for brain amyloid was a highly significant predictor of progression from amnestic Mild Cognitive Impairment (aMCI) to probable Alzheimer’s disease (pAD).

Norvision announced the successful implementation of the Norvision Skylite In-ceiling Video-wall.

Based on its recent analysis of the magnetic resonance imaging (MRI) market, Frost & Sullivan recognized Siemens Healthcare with the 2014 North American Award for Product Leadership. Siemens Healthcare's Freezeit solution, which employs Siemens' Magnetom Aera and Skyra scanners, addresses the need for robust and motion-insensitive imaging. The solution's sophistication and utility in patient care has boosted the evolution of body MRI imaging in the U.S. market.